Search

everythinglearnresearchcommunity

for

Search:↓

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Higher androgen receptor levels in bald areas may cause hair loss, while estrogen receptors have less impact.

Treatments for hair loss include estrogen therapy and special shampoos.

Genetics, low estrogen, and low iron levels contribute to female hair loss, with specific scalp signs indicating severity.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Human sebaceous glands can grow normally for a week without certain growth factors, and adding estrogen reduces their oil production without affecting cell growth.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.